Article

How to begin a survivorship program in your community oncology practice


 

In 2012, the United States had an estimated 12 million cancer survivors. 1 In November 2005 the Institute of Medicine (IOM) issued a call to action on cancer survivorship for health care professionals to recognize challenges, treat conditions, and support our patients more comprehensively after their diagnosis with cancer. 2 This support begins with educating patients about their disease and treatment, their follow-up plan, and potential complications. It involves an assessment for potential complications of disease and treatment, and intervention when warranted. Survivorship programs have emerged throughout the country, but the composition of the programs and operational process by which they are implemented are widely varied. There is some divergence about what defines a cancer survivor, though most current programs treat individuals who have undergone early stage disease treatment through palliation. The site of service where survivorship programs are delivered varies from hospital to center to clinic. The structure of the delivery mechanism can be as a consultation, assuming individuals will have usually 1 survivorship visit, or as longitudinal, setting the precedent that patients will follow up at some regular interval for continued survivorship care. The most striking variation in survivorship programs is the depth and breadth of services that they provide to their patients.

*Click on the links to the left for PDFs of the full article and related article and Commentary.

Recommended Reading

Locally advanced pancreatic cancer in a socio-economically challenged population
MDedge Hematology and Oncology
Improving access with a collaborative approach to cancer genetic counseling services: a pilot study
MDedge Hematology and Oncology
Minimizing cancer’s impact on bone with denosumab: current and future perspectives
MDedge Hematology and Oncology
PD-L1 blockers take center stage at ASCO 2013
MDedge Hematology and Oncology
Avoid transcutaneous biopsy in adrenocortical carcinoma
MDedge Hematology and Oncology
Sen. Cardin hears doctors’ concerns on ACA
MDedge Hematology and Oncology
SGR replacement cost now up to $176 billion
MDedge Hematology and Oncology
U.S. physician population grew fastest in South Atlantic region
MDedge Hematology and Oncology
Uninsured number holds steady during ACA implementation lull
MDedge Hematology and Oncology
Continued slowdown in health spending not due to health reform
MDedge Hematology and Oncology